Sodium Nitroprusside in Early Course Schizophrenia

Clinical trial NCT04986072 · TERMINATED

Trial details

NCT number: NCT04986072
Sponsor: Beth Israel Deaconess Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2022-03-14
Primary completion: 2024-06-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.